index - Myopathies inflammatoires & thérapies innovantes ciblées Accéder directement au contenu

Dernières publications

Chiffres clés

123 Publications avec texte intégral

Open Access

53 %

Mots clés

B cell homeostasis Gene therapy Outcome measures Analyses multidimensionnelles Autoimmune diseases Cytokines Adjudication Anémie hémolytique AAV vector Anti-synthetase syndrome Amyotrophy Bioelectrical impedance analysis Myopathy Auto-immunité Inborn errors of metabolism Immune checkpoint inhibitors Sphingosine-1-phosphate Anti-IgE IgG Antisynthetase Prognosis Anticorps spécifique des myosites Myositis Anticorps anti-agalsidase Biomarkers Mass cytometry AAV vectors Male Adverse drug reactions Antibodies Antisynthétase Immunotherapy Middle Aged Humans Anti‐mitochondrial antibodies Anti-interleukin-6 Biopsy Fabry disease Aged Adolescence Multidisciplinarity Antibody responses Myositis and muscle disease IBM Idiopathic inflammatory myopathies Female Auto‐antibodies Aldosterone AAV antibody Aldostérone AAV humoral immunity Acid-alpha-glucosidase Anti-drug antibodies Adeno-associated virus Cardio-oncology Lysosomal storage diseases Deep immune profiling Machine learning Acute Kidney Injury/epidemiology/etiology Biomarqueurs B-lymphocyte AAV Data integration Anti-Mi2 Active Antisynthetase syndrome Auto-antibodies Muscle Autoantibody Assisted communication devices Autoantibodies Anti-agalsidase antibodies Inflammatory myopathy IMNM Arthritis Inclusion body myositis Biomarker Interferon Myocarditis DM Adult Dependovirus/genetics/immunology Interstitial lung disease Animals Adeno-associated vector Amyotrophic lateral sclerosis Pharmacology Polymyositis Adeno-associated virus vector Dermatomyositis Anti-MDA5 autoantibodies Cancer Inflammation Systems biology Abnormal movement COVID-19 Agalsidase Skeletal muscle Case reports Antiphospholipid syndrome Autoimmunity